Never miss a great news story!
Get instant notifications from Economic Times
AllowNot now


You can switch off notifications anytime using browser settings.

News

Brokerage Radar: CLSA on pharma and telecom sectors

CLSA ON BHARTI AIRTEL
1/3

CLSA ON BHARTI AIRTEL

>> Focus on ramping-up 4G data subscribers

>> An unlikely disruption of fixed-line broadband

>> No compulsion for further asset sales

>> Favourable risk-reward; retain BUY

>> Raises target price from Rs390 to Rs415

Shutterstock.com
CLSA ON INDIAN PHARMA
2/3

CLSA ON INDIAN PHARMA

>> Second consecutive month of double-digit growth, TTM growth at 11%

>> Growth momentum continues, with IPM growing 13.7% YoY in August

>> Ipca saw strongest growth (within coverage) followed by Glenmark and Dr Reddy’s

Shutterstock.com
CLSA INDIA STRATEGY
3/3

CLSA INDIA STRATEGY

>> Investor and corporate commentary has been weak

>> EM flows could improve as yields vs PE equation looking better

>> Global investors still overweighted on India

>> PSU banks have started buying portfolios from NBFCs under the “backstop” scheme

>> Govt may bring in netting legislation during the next parliament session

>> Govt may offer demand incentives going forward for property sector

>> Among laggards, there is incremental FII interest in autos, pharma and PSUs

>> Flows to EMs, India could improve is Fed cuts more than 50bps

Shutterstock.com
X
User

Other useful Links


Follow us on


Download et app


Copyright © 2019 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service